The WACC of Affimed NV (AFMD) is 15.7%.
| Range | Selected | |
| Cost of equity | 29.30% - 84.50% | 56.90% |
| Tax rate | -% - -% | -% |
| Cost of debt | 7.00% - 21.70% | 14.35% |
| WACC | 7.7% - 23.7% | 15.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 5.53 | 14.22 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 29.30% | 84.50% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 29.99 | 29.99 |
| Cost of debt | 7.00% | 21.70% |
| After-tax WACC | 7.7% | 23.7% |
| Selected WACC | 15.7% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for AFMD:
cost_of_equity (56.90%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (5.53) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.